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use#LAAApril  25th  2013  is  the  sixtieth  anniversary  of  the 
infamous Watson and Crick Nature paper describing a 
model for the structure of DNA, published 25 April 1953: 
the now infamous ‘double helix’ [1]. Two accompanying 
papers  from  Rosalind  Franklin,  Maurice  Wilkins  and 
colleagues  leant  experimental  support  to  the  proposed 
structure in the form of X­ray diff  raction data [2,3], as 
described elsewhere in this issue of Genome Biology [4]. 
Th   e model was a landmark discovery in the history of 
modern science, and was notable for its cross­disciplinary 
importance:  the  question  addressed  was  of  immense 
biological importance, but it was physicists and chemists 
whose expertise and techniques were needed in order to 
arrive at an answer. One of these physicists, Ray Gosling, 
describes  the  unveiling  of  Watson  and  Crick’s  double 
helix structure as a ‘eureka’ moment [4]: its simplicity and 
elegance were striking, and not only explained the X­ray 
diff  raction data but also the mode of replication of life 
itself. It is rare for a scientifi  c discovery to achieve such 
an  iconic  status,  to  pervade  popular  culture  and  the 
public consciousness, as well as to become an emblem of 
scientifi  c  inquiry  ­  as  exemplifi  ed  by  Genome  Biology’s 
double helix­inspired logo. Although Avery had already 
shown DNA to be the genetic material [5], it took the 
convincing simplicity of Watson and Crick’s double helix 
for this notion to widely take hold, in place of theories 
favoring  proteins.  Th   e  discovery,  therefore,  had  many 
important  implications,  and  set  the  scene  for  future 
breakthroughs in the fi  eld of genome biology.
To celebrate sixty years of such discoveries, we asked a 
jury  composed  of  Genome  Biology  Editorial  Board 
members to select key advances in the fi  eld since 25 April 
1953. Th   e brief was to choose a development that was 
either the most important or the most surprising, or that 
had the most personal impact, and to briefl  y summarize 
why.  A  number  of  selections  focused  on  technological 
advances ­ from restriction mapping through microarrays 
and  high­throughput  sequencing.  Th   ese  technologies 
have clearly done much to inform our understanding of 
the biology of genomes. Th   e most popular choice, how­
ever, was the discovery of introns. Much like the double 
helix, this discovery had something of the ‘X factor’ to it: 
biologists  trained  in  the  post­intron  era  may  take  the 
concept  of  gene  fragmentation  for  granted,  but  at  the 
time  it  was  a  truly  radical  and  paradigm­shifting  idea. 
Th   e sense of surprise made a strong impression on those 
old enough to remember the discovery, and one of the 
groups involved went so far as to describe it as ‘amazing’ 
in the title of their paper [6].
‘Genes in pieces’: introns
Brenton Graveley
In  1977,  Rich  Roberts  and  Phil  Sharp  independently 
reported that genes can be interrupted by introns [6,7]. 
In my opinion, this is the biggest and most surprising 
discovery in genome biology since the structure of DNA 
was reported by Watson and Crick on 25 April 1953 [1]. 
Accordingly, Roberts and Sharp were awarded the Nobel 
Prize  in  Physiology  or  Medicine  in  1993  for  this  dis­
covery. Th   e existence of introns was entirely unexpected, 
and led to the subsequent discovery of the spliceosome, 
the  macromolecular  complex  that  removes  introns. 
Alternative splicing, where exons can be joined together 
in  diff  erent  patterns,  is  known  to  occur  for  nearly  all 
human genes and plays important roles in both increas­
ing protein diversity and regulating biological processes. 
Th   e implications of these fi  ndings are very far reaching 
and  it  is  now  known  that  many  human  diseases  are 
caused by mutations in the RNA sequences that direct 
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and regulate intron removal.
Jernej Ule
Walter Gilbert wrote an opinion article in 1978 beginning 
with  the  statement,  ‘Our  picture  of  the  organisation  of 
genes in higher organisms has recently undergone a revo­
lu  tion’  [8].  In  1977,  the  Roberts  and  Sharp  groups 
reported that viral mRNA molecules were shorter than 
their  corresponding  genes  [6,7].  By  1978,  a  flurry  of 
papers  demonstrated  that  most  genes  in  eukaryotic 
organ  isms contain regions that are removed during the 
production of mRNAs. In his article, Gilbert proposed 
that we call these regions ‘introns’ (for intragenic regions).
Despite knowing the sequence of only a small number 
of genes in 1978, Gilbert was able to correctly predict 
that introns account for approximately ten times more 
genomic sequence than exons. But what was the function 
of  this  prevalent  genomic  feature?  Since  introns  are 
removed from the nascent RNA, they marked a departure 
from  early  studies  of  genetic  code.  Introns  did  not  fit 
easily into the simple, linear transfer of genetic infor  ma­
tion  from  DNA  to  mRNA  to  protein.  They  required  a 
different kind of thinking.
Gilbert predicted that parts of introns could in some 
cases become exons, a process that we now recognize as 
alternative splicing. Alternative splicing would increase 
protein  diversity  and,  if  its  regulation  was  cell­type 
specific, it might even drive cellular differentiation. These 
hypotheses  have  since  been  validated  by  decades  of 
research. Moreover, Gilbert envisioned that introns could 
be  fertile  ground  for  evolutionary  tinkering,  since 
mutations that modulate inclusion of exons could change 
the patterns of alternative splicing.
‘The  extra  material  is  scattered  in  the  genome,  to  be 
called  into  action  at  any  time...  Evolution  can  seek  new 
solutions without destroying the old.’ Here, Gilbert suggests 
that mutations can create novel mRNA isoforms without 
removing  the  previous  isoforms.  Thus,  in  spite  of  the 
apparent burden of extra genomic sequence, introns create 
a mechanism primed to explore evolutionary innovations. 
The idea that life has a vast in­built potential that remains 
to be realized had a strong impact on my thinking and 
research. This led us to the recent findings that the human 
genome contains a reservoir of transposable elements that 
can gradually evolve into exons by mutations that influence 
the  competitive  binding  of  multiple  splicing  factors  [9]. 
Gilbert summarized the dual nature of introns as burden 
and blessing with typical elegance, ‘introns are both frozen 
remnants of history and the sites of future evolution.’
Steven Henikoff
I was just finishing up as a graduate student in 1977 when 
I first learned of the amazing discovery of split genes in 
adenovirus  [6,7].  Shortly  thereafter,  rumors  circulated 
that genes in pieces, or what Wally Gilbert referred to as 
exons  and  introns  [8],  are  far  more  common  than 
originally supposed, and in fact are the rule, rather than 
the exception. It was a thrill to realize that something 
that  we  all  took  for  granted,  from  the  dominant 
Escherichia  coli  paradigm  of  uninterrupted  protein­
coding genes, does not hold in eukaryotic genomes. It is 
hard to think of another example in which a concept so 
fundamental  as  split  genes  and  post­transcriptional 
splicing was not suspected to exist before its discovery. 
Wally began the debate over ‘why?’ [8] and others asked 
‘how?’  [10],  but  for  me,  the  question  was:  what  other 
surprises  lay  in  store  in  the  realm  of  eukaryotic  gene 
organization?  Thus  began  my  interest  in  what  later 
became referred to as genomics, and when I had my own 
lab,  studying  genes  in  pieces  led  to  the  surprising 
discovery of genes in pieces in genes in pieces [11].
Ford Doolittle
The discovery of spliceosomal introns in the genomes of 
eukaryotes [12­15] ranks very near the top of my list, in 
‘significance, surprise and (especially) personal impact’. I 
was at the time (1977) on sabbatical in the lab of Wally 
Gilbert and he, having just become aware of that amazing 
discovery, came up with ‘exon shuffling’ as an appealing 
raison­d’etre  for  introns’  existence  [8].  Because  I  also 
knew  of  Carl  Woese’s  then  very  recent  discovery  of 
archaea and Carl’s inference therefrom that eukaryotes 
and prokaryotes might have diverged separately from a 
more primitive common ancestor [16], and because I did 
not believe that early eukaryotes would have taken on the 
burden of introneousness just because it might help them 
in the distant future, I cobbled together the theory that 
became known as ‘introns early’ [17].
Almost  certainly  that  theory  is  false:  it  seems  much 
more likely that spliceosomal introns are Group II introns 
gone to seed ­ fallen apart into ‘five easy pieces’ [18] and 
increasingly  dependent  on  dozens  of  proteins,  the 
accretion  of  which  may  have  been  largely  through  a 
neutral  evolutionary  ratchet.  But  ‘introns  early’  had  a 
great run, in large part thanks to Wally, and stimulated 
many  to  think  more  deeply  about  the  evolution  and 
functional significance of genome architecture. In parti­
cular, it forced us to accept that Dobzhansky’s rubric that 
‘nothing  in  biology  makes  sense  except  in  the  light  of 
evolution’ is just as valid at the molecular level as the 
organismal. Genomes are much more than repositories 
of encoded information needed to make organisms, and 
we can be led astray if we adopt an overly functionalist/
adaptationist  perspective.  Genomicists  and  systems 
biologists are especially at risk of doing this, as the recent 
controversy surrounding the ENCODE project illus  trates 
[19].
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George Weinstock
When I started graduate school in 1970 there were no 
restriction  enzymes  and  agarose  gels,  let  alone  DNA 
sequences. Genetics was dominated by model organisms 
like E. coli, phage lambda, Saccharomyces cerevisiae and 
Drosophila melanogaster. It was based on linkage maps 
and  recombination  frequencies,  complementation  tests 
and  cistrons,  abstract  concepts  that  only  a  geneticist 
could love and that probably made the field less accessible 
to  other  biologists.  There  were  experiments  relating 
genetic traits to physical locations on a chromosome, but 
these were relatively low resolution and had only limited 
impact on converting our view of the genome from the 
abstract  concepts  of  genetic  methodology  to  the  bio­
chemical  reality  of  DNA  structure.  Then,  in  the  mid­
1970s,  restriction  enzymes  [20,21]  and  agarose  gels 
[22,23]  began  to  change  all  of  that.  Suddenly  it  was 
possible  to  reduce  the  abstractions  of  linkage  maps  to 
detailed restriction maps (for example, [24]) with con­
crete  physical  distances  instead  of  operational  but 
obscure recombination frequencies. Being able to view 
genome structure in these tangible terms was a paradigm 
shift that made for a more comfortable way of describing 
genome  structure  for  both  the  biologist  and  lay  com­
munity. Of course, all of that led to great downstream 
advances ­ PCR, DNA sequencing, and much more. Now 
most biologists only think of genomes in palpable terms, 
never  in  the  abstract  genetic  concepts,  and  probably 
would  have  a  hard  time  imagining  how  you  could  do 
research without this. So to me, that DNA technology of 
the  mid­1970s  was  the  day  genetics  changed  and  we 
shifted from one era to the next.
A new regulatory paradigm: microRNA
John Rinn
The laws of genetics have never depended on what genes 
are made of chemically, and would hold true even if they 
were made of green cheese.
Ed Lewis
Genetic  approaches  are  as  fundamental  to  biology  as 
math  is  to  physics.  One  of  the  most  bizarre,  dogma­
shifting and inspiring genetic studies is exemplified in the 
article  by  Victor  Ambros  and  colleagues  entitled  ‘The 
C. elegans heterochronic gene lin­4 encodes small RNAs 
with antisense complementarity to lin­14’ [25]. The study 
was  published  alongside  related  findings  from  Gary 
Ruvkun and colleagues [26].
As a testament to the strength of genetics, Ambros and 
colleagues went to heroic lengths to identify the function 
of  the  lin­4  gene,  which  Horvitz  and  Sulston  had 
previously identified in a forward genetic screen for novel 
Caenorhabditis  elegans  cell­lineage  mutants  [27].  Dr 
Ambros’ lab started to investigate the mechanistic role of 
lin­4, using classic complementation to hone in on the 
gene product. They narrowed the locus down to a 3.2 kbp 
region, and then further refined it to a 693 bp region, that 
could complement or recover the lin­4 mutant phenotype 
of delayed development. Typically, this genetic resolution 
would have identified a protein­coding exon, leading to a 
more obvious explanation of the lin­4 gene product.
The first twist in this expedition into ‘noncodarnia’ was 
that the gene mapped not to a coding region, but within 
an intron of a protein­coding mRNA. Dogmatically, this 
region was already doomed to be labeled as junk, based 
on being encoded within an intron. Even worse, Northern 
blot and RNase protection analyses identified 61 nucleo­
tide and 22 nucleotide RNA species, which was smaller 
than any protein mRNA known at the time. Grounded in 
purely  genetic  observations,  the  authors  continued  to 
pursue  the  most  heroic  genetic  exercise  in  this  study: 
non­complementation.  After  surveying  no  less  than 
20,000 mutants of the lin­4 bearing chromosome, only 
one was unable to complement the original lin­4 mutant. 
The source was a C­to­T transition within both the 61 
nucleotide and 22 nucleotide lin­4 RNA species. Thus, 
despite beginning with a most unorthodox genetic obser­
vation, the authors now had evidence that a mutation in 
this tiny RNA could indeed recapitulate the original lin­4 
mutant.
Taking these observations at face value, the authors put 
forward a model ­ perhaps the only possible model ­ in 
which this deviant 22 nucleotide or 61 nucleotide RNA 
hybridizes to the 3’ UTR of the lin­14 gene, and in doing 
so serves as a negative inhibitor. The inhibition of lin­14 
would  explain  the  original  observation  of  delayed 
development  in  lin­4  mutants.  The  unquestionable 
genetics underlying the interplay of lin­4 and lin­14 led, 
ten years ahead of its time, to a model that has become 
dogma. We now know, of course, that the authors had 
dis  covered a whole new form of gene regulation, wide­
spread in nature, mediated by what Ambros and others 
[28­30]  eventually  christened  microRNAs,  or  miRNAs. 
The visionary discussion section of Ambros and colleagues’ 
lin­4 article simply raises intellectual goosebumps.
The authors never deviated from the inherent truths of 
genetic observation, no matter how odd the underlying 
gene  product.  Despite  having  discovered  this  abstruse 
gene product, which in its day smelled something like 
green cheese, the genetic basis and implications were to 
them clear, correct and prophetic.
The original ‘data explosion’: microarrays
Alicia Oshlack
Ten years ago, I had no real concept of DNA. Genes, in 
my limited understanding, were passed down to you by 
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between genes and DNA. My awareness was focused on 
the outer reaches of the universe and contemplating how 
gases  revolve  around  black  holes  in  the  centers  of 
quasars: my PhD topic. Had it not been for the discovery 
of microarrays, I may never have had the opportunity to 
turn my scientific career on its head and begin training in 
bioinformatics.  The  first  expression  microarrays  were 
published in 1995 by Pat Brown’s group at Stanford [31], 
and by 2003 hundreds of discoveries were being made 
using the many different versions of this technology. The 
invention  of  microarrays  produced  a  data  explosion 
(although perhaps not as phenomenal as the one we are 
currently  experiencing)  and  with  this  came  a  need  for 
quantitative scientists to develop analysis methodology 
and  interpretation  of  data.  I  was  fortunate  enough  to 
have been given an opportunity to join the bioinformatics 
division  of  two  pioneers  in  the  field  of  microarray 
analysis, Gordon Smyth and Terry Speed. I consider the 
first couple of years of the job akin to a second PhD, in 
which my primary focus was methodology development 
for the analysis of microarray data. If it had not been for 
the invention of expression microarrays, my career may 
have ended up light years away from what I now believe 
to be the most interesting job in the world.
Unlocking ‘genetic messages’: sequencing 
technologies
Michael Schatz
The  most  significant  development  in  genome  biology 
since 25 April 1953 has been the rise of large­scale DNA 
sequencing, pioneered by Fred Sanger in 1977 [32], and 
refined over the last several decades in first, second, and 
now  third  generation  automated  sequencing  techno  lo­
gies.  Determining  the  structure  of  DNA  in  1953  was 
incredibly  significant  for  determining  the  molecular 
framework for so many aspects of biology, including the 
frameworks  for  replication,  transcription,  inheritance, 
mutation  and  evolution,  to  name  but  a  few.  However, 
determining  the  structure  of  DNA  is  analogous  to 
determining the structure of a piece of paper, void of any 
literature or mathematics written upon it. Now, with the 
rise of high­throughput sequencing, we have the capa­
bility  to  read  the  genetic  messages  written  on  those 
molecular pages. This capability has unlocked not only 
the human genome but also those of thousands of other 
species, revealing their genes, regulatory sequences and 
overall  structures,  which  has  in  turn  led  to  many 
important advances in biology and medicine. The next 
frontier in genome biology is to apply these technologies, 
and  the  related  molecular  assays  empowered  by  DNA 
sequencing, over large populations of species, individuals 
and  cells  to  compare,  model  and  predict  how  these 
systems behave.
‘Sequence is power’: the human and mouse 
genome projects
Chris Ponting
To me, one important moment in genomics was in 2002 
when we could measure the human genome against an 
evolutionary yardstick, the mouse genome. Jim Kent of 
UCSC produced a wonderful visual guide (Figure 25a in 
[33])  to  the  most  important  features  of  mammalian 
genes.  By  collapsing  levels  of  sequence  conservation 
between thousands of mouse and human orthologs into 
one metagene, he showed how, from a common sequence 
over  90  million  years  ago,  mutation  has  etched  away 
intronic sequence whilst selection has greatly preserved 
the exons, particularly toward their boundaries. For me, 
Jim’s analysis was important in illustrating so very clearly 
how evolutionarily dynamic are our genes and genomes.
Mark Gerstein
I think the most significant advance in genomics since 
the unraveling of the double helical structure in 1953 has 
been the sequencing of the first personal genome, that of 
Craig Venter. The sequencing of a personal genome, not a 
reference  or  anonymous  genome,  links  genomics  to 
people and transforms the field from an abstract science 
of molecules to something very personal and connected 
to humankind. When we look back on 1953 from 2053, 
we will realize that the personal genome is what really 
brought DNA to the masses.
Peter Fraser
I  suppose  the  most  important  ‘happening’  in  genome 
biology  since  1953  would  have  to  be  the  human  and 
mouse genome projects [33,34]. Prior to the completed 
sequences,  these  genomes  were  a  seemingly  infinite 
mystery. Individual investigators clung onto and pored 
over  a  few  hard­fought  kilobases  of  DNA  sequence 
around their genes of interest. Going much beyond this 
in a time when sequences were still determined on gels 
was  akin  to  interstellar  travel.  The  genome  projects 
essen  tially turned each genome into a global village of 
finite proportions that is now rapidly filling with features. 
Though the genome projects themselves are not really a 
discovery,  they  have  made  possible  countless  other 
discoveries.  I  have  decided  to  focus  on  one  of  these 
smaller  discoveries,  important  in  its  time,  but  one  of 
more  personal  significance.  It  serves  as  an  excellent 
example of the many discoveries that the genome projects 
revolutionized. The discovery was of the properties of the 
beta­globin  dominant  control  region,  also  called  the 
locus activating region and later named by committee as 
the  locus  control  region.  This  was  a  region  about 
50 kilobases upstream of the beta­globin gene that was 
known to have profound effects on globin gene expres­
sion [35]. The element was in the dark area of the genome 
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light  of  the  gene­local  kilobase  or  so  of  sequences 
flanking the globin genes. Instead of sequence, only pain­
stakingly  determined  restriction  maps  existed  for  this 
distant region. After discovery of its function, the focus 
switched to how such a long­range element could affect 
gene expression over such a distance. The debates were 
lively, passionate, some would say fierce, and this not only 
energized  the  field  but,  finally,  15  years  later,  led  to 
experiments that provided evidence for a physical inter­
action­based  mechanism,  via  long­range  folding  or 
‘looping’ of chromatin [36]. During this time, the various 
genome projects were gradually increasing the amount of 
genomic sequences available. Soon it was realized that 
many  genes  were  controlled  by  long­range  elements, 
some up to a megabase away, and nowadays it appears 
that most, if not all, genes may be controlled by many 
such elements [37]. But it didn’t stop there; built on the 
foundation of the complete genome sequence and fuelled 
by advanced high­throughput sequencing technologies, 
the folding of these individual loops into chromosomes, 
together  with  the  way  chromosomes  are  arranged  and 
interact in the nucleus, is increasingly being appreciated 
as  an  important  contributing  factor  to  the  control  of 
many genome functions [38,39]. So, although the monu­
mental genome projects are the antithesis of the elegance 
of the Watson and Crick model, they must be seen as 
equally  significant  because  of  their  present  and  future 
impacts. Sequence may not be knowledge, but it is power.
Retelling the human story: analysis of ancient and 
historical DNA
Detlef Weigel
‘What has been the most surprising discovery in the field 
of genome biology for you?’ In hindsight, it appears that 
many  applications  of  high­throughput  sequencing,  in 
which I include automated Sanger sequencing, have long 
been  obvious.  Certainly,  being  able  to  read  entire 
genomes was in principle already thinkable when I was in 
college  in  the  early  1980s.  What  I  believe  would  have 
been  very  difficult  to  imagine  is  the  ability  to  study 
genomes  from  organisms  that  have  been  dead  for 
thousands or even tens of thousands of years. The vision 
that my Max Planck colleague Svante Pääbo has had in 
this regard, and the dogged manner with which he has 
pursued the sequencing of ancient genomes, is absolutely 
remarkable.  The  work  of  Svante  and  his  students  has 
already  revolutionized  our  understanding  of  human 
evolution  in  the  distant  past  [40­48].  I  believe  it  has 
similar  potential  for  changing  our  knowledge  of  more 
recent  history.  A  taste  of  what  I  am  certain  is  an 
imminent avalanche of such studies has been provided by 
Bos  and  colleagues’  Nature  study  exploring  the  Black 
Death outbreak in medieval times [49].
The exception to the rule: lateral gene transfer
Curtis Huttenhower
I would suggest the discovery of horizontal gene transfer 
as one of the most remarkable in the history of genome 
biology. First, it arguably predates the discovery of the 
structure  of  DNA  itself,  having  been  implicated  in 
Frederick  Griffith’s  transformation  experiment  in  1928 
[50]. As happens too often in biology, this simultaneously 
introduced  both  a  rule  (DNA  as  the  agent  of  vertical 
genetic transmission) and its exception (lateral transfer). 
Second,  this  apparently  straightforward  concept  was 
gradually  shown  to  comprise  a  diversity  of  related 
biological mechanisms, perhaps culminating with Joshua 
Lederberg’s 1951 work on phage transduction [51] and 
1958 Nobel Prize for bacterial recombination. Even then, 
the  extent  and  plasticity  of  lateral  transfer  were  only 
emphasized  later  in  the  1983  Nobel  Prize  to  Barbara 
McClintock for the discovery of distinct mobile genetic 
elements ­ a discovery made decades earlier [52] but not 
widely accepted until the 1970s. The range of mechanisms 
by which transfer occurs has had implications as practical 
as driving the spread of antibiotic resistance and as far­
flung  as  casting  doubt  on  the  reconstruction  of  a 
universal tree of life. Third, horizontal transfer is notable 
in remaining an area of active research almost a century 
after its discovery. Its implications in ancient evolution or 
in eukaryotes are not yet clear. Likewise, its prevalence, 
dynamics,  ecology,  and  functional  consequences  in 
micro  bial communities continue to be explored. I hope 
that the 100th anniversary of DNA sees an even longer 
list of biological ramifications of horizontal gene transfer 
and continued discoveries in the field.
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